{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:00:27Z","timestamp":1786546827357,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2113"],"award-info":[{"award-number":["JPMJSP2113"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04929-2","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:58:33Z","timestamp":1786499913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database"],"prefix":"10.1007","volume":"96","author":[{"given":"Shiho","family":"Ueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2033-4246","authenticated-orcid":false,"given":"Takahiro","family":"Niimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emika","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Tsujinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Io","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuka","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Chuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Izawa-Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"4929_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.4049\/jimmunol.130.3.1473","volume":"130","author":"D Mew","year":"1983","unstructured":"Mew D, Wat CK, Towers GH, Levy JG (1983) Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol 130:1473\u20131477","journal-title":"J Immunol"},{"key":"4929_CR2","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","volume":"52","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Choyke PL (2019) Near-infrared photoimmunotherapy of cancer. Acc Chem Res 52:2332\u20132339. https:\/\/doi.org\/10.1021\/acs.accounts.9b00273","journal-title":"Acc Chem Res"},{"key":"4929_CR3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/nm.2554","volume":"17","author":"M Mitsunaga","year":"2011","unstructured":"Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H (2011) Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 17:1685\u20131691. https:\/\/doi.org\/10.1038\/nm.2554","journal-title":"Nat Med"},{"key":"4929_CR4","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1007\/s10147-021-01960-6","volume":"26","author":"M Tahara","year":"2021","unstructured":"Tahara M, Okano S, Enokida T, Ueda Y, Fujisawa T, Shinozaki T, Tomioka T, Okano W, Biel MA, Ishida K, Hayashi R (2021) A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma. Int J Clin Oncol 26:1812\u20131821. https:\/\/doi.org\/10.1007\/s10147-021-01960-6","journal-title":"Int J Clin Oncol"},{"key":"4929_CR5","unstructured":"Rakuten Medical Inc Akalux IV infusion 250\u00a0mg. Package insert. https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00069015.pdf. Accessed 17 April 2025"},{"key":"4929_CR6","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.3390\/cancers15215117","volume":"15","author":"NL Miyazaki","year":"2023","unstructured":"Miyazaki NL, Furusawa A, Choyke PL, Kobayashi H (2023) Review of RM-1929 Near-infrared photoimmunotherapy clinical efficacy for unresectable and\/or recurrent head and neck squamous cell carcinoma. Cancers (Basel) 15:5117. https:\/\/doi.org\/10.3390\/cancers15215117","journal-title":"Cancers (Basel)"},{"key":"4929_CR7","unstructured":"Pharmaceuticals and Medical Devices Agency Japanese adverse drug event report database. https:\/\/www.pmda.go.jp\/safety\/info-services\/drugs\/adr-info\/suspected-adr\/0004.html. Accessed 26 July 2025"},{"key":"4929_CR8","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/s0140-6736(08)60728-x","volume":"371","author":"A Argiris","year":"2008","unstructured":"Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695\u20131709. https:\/\/doi.org\/10.1016\/s0140-6736(08)60728-x","journal-title":"Lancet"},{"key":"4929_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1468-3083.2009.03490.x","volume":"24","author":"H Tomkov\u00e1","year":"2010","unstructured":"Tomkov\u00e1 H, Kohoutek M, Z\u00e1bojn\u00edkov\u00e1 M, Posp\u00edskov\u00e1 M, Ostr\u00edzkov\u00e1 L, Gharibyar M (2010) Cetuximab-induced cutaneous toxicity. J Eur Acad Dermatol Venereol 24:692\u2013696. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03490.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4929_CR10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1200\/jco.2006.06.7447","volume":"25","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Trigo J, Hitt R, Koralewski P, Diaz-Rubio E, Rolland F, Knecht R, Amellal N, Schueler A, Baselga J (2007) Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 25:2171\u20132177. https:\/\/doi.org\/10.1200\/jco.2006.06.7447","journal-title":"J Clin Oncol"},{"key":"4929_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/nejmoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578. https:\/\/doi.org\/10.1056\/nejmoa053422","journal-title":"N Engl J Med"},{"key":"4929_CR12","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1002\/cam4.1623","volume":"7","author":"S Iwamoto","year":"2018","unstructured":"Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K (2018) A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial. Cancer Med 7:4217\u20134227. https:\/\/doi.org\/10.1002\/cam4.1623","journal-title":"Cancer Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04929-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:03:21Z","timestamp":1786543401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04929-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04929-2","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}